Memorial Sloan Kettering Cancer Center

203 articles about Memorial Sloan Kettering Cancer Center

• Memorial Sloan-Kettering Cancer Center Received $50k Impact Award From Hyundai Hope On Wheels To Support Pediatric Cancer Care For Teens And Young Adults

  3/28/2016

• Foundation Medicine, Inc. And Memorial Sloan-Kettering Cancer Center Publish Validation Data For Foundationone Heme In The Journal Blood

  3/24/2016

• ImmunID Signs Master Collaboration Agreement With Memorial Sloan-Kettering Cancer Center About The Prediction Of Response To Immuno-Oncology Agents Using ImmunTraCkeR

  2/23/2016

• Gritstone Oncology Enters Into Exclusive Licensing Agreement And Collaboration With Memorial Sloan-Kettering Cancer Center

  1/12/2016

• Eureka Therapeutics Announces Exclusive License Agreement Between Memorial Sloan-Kettering Cancer Center And Juno For Use Of A Novel, Fully-Human MUC16 Binder In CAR T Cell Immunotherapy

  1/7/2016

• Actinium Pharmaceuticals, Inc. And Memorial Sloan-Kettering Cancer Center Sign Agreement In Respect Of Certain Liquidity Matters

  12/28/2015

• Adimab LLC. Establishes Antibody Discovery Collaborations With MD Anderson Cancer Center And Memorial Sloan-Kettering Cancer Center

  12/8/2015

• Genocea Announces Immuno-Oncology Research Collaboration With Memorial Sloan-Kettering Cancer Center

  11/5/2015

• Advaxis Enters Personalized Medicine Space With Memorial Sloan-Kettering Cancer Center Collaboration

  10/28/2015

• Cesca Therapeutics Enters Into Collaborative Agreement With Center For Immune Cell Therapies At Memorial Sloan-Kettering Cancer Center

  9/17/2015

• Memorial Sloan-Kettering Cancer Center And Illumina Launch Comprehensive Circulating Tumor DNA Program

  9/16/2015

• Atara Biotherapeutics Exercises Exclusive License To T-Cell Technology From Memorial Sloan-Kettering Cancer Center

  6/15/2015

• Memorial Sloan-Kettering Cancer Center Selects PDS Life Sciences’ Ascentos Software For Preclinical Research

  5/27/2015

• C3 Summit & Lead Sponsors CDC, Memorial Sloan-Kettering Cancer Center, Dubai Harvard Foundation For Medical Research Address "A New Middle East Without Virus C"

  4/6/2015

• Memorial Sloan-Kettering Cancer Center Snags Breakthrough Designation From the FDA

  3/2/2015

• Enumeral Biomedical And Memorial Sloan-Kettering Cancer Center To Research Cancer Immunology With Advanced Prototype System For Human Tissue Immuno-Oncology Profiling

  1/12/2015

• MabVax Therapeutics, Inc. And Memorial Sloan-Kettering Cancer Center Report On Potential Use Of Dual-Labeled Antibody To Detect And Guide Surgical Removal Of Pancreatic Cancer

  11/19/2014

• Atara Biotherapeutics Announces Immunotherapy Alliance With Memorial Sloan-Kettering Cancer Center

  9/23/2014

• Relmada Therapeutics Enters Into Agreement With Memorial Sloan-Kettering Cancer Center To Better Clarify Unique Mechanism Of Action For LevoCap ER

  9/16/2014

• MabVax Therapeutics, Inc. Enters Agreements With Memorial Sloan-Kettering Cancer Center And Juno Therapeutics For Development Of Anti-Cancer Therapeutics

  9/10/2014